3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Unknown
18
Recruiting
6
Not yet recruiting
4
Active not recruiting
4
Enrolling by invitation
1
Completed
1
Sponsor Class
UNKNOWN
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Carcinoma, Non-Small-Cell Lung
1
Interventions
Pemetrexed
2
trilaciclib
1
trastuzumab deruxtecan
1
pembrolizumab
1
lorlatinib
1
aumolertinib
1
Gemcitabine
1
Cisplatin
1
Carboplatin
1
Anterior Temporal Lobectomy
1
Afatinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Enrolling by invitation
×
Carcinoma, Non-Small-Cell Lung
×
aumolertinib
×
Clear all
NCT04762459
2022-02-24
APEX
ChineseAMS
Phase 3
Enrolling by invitation
606 enrolled